Dumitraşcu D L, Radu D, Vonica A
Institute of Hygiene and Public Health, Department 3rd Medical Clinic, Cluj-Napoca, Romania.
Rom J Intern Med. 1991 Jul-Dec;29(3-4):151-4.
Antithrombin III is an anticoagulant synthesized in the liver cells. The aim of this study was to estimate the serum level of antithrombin III in cirrhotics. Investigations were carried out in 32 patients with cirrhosis and in 20 healthy controls. Antithrombin III measured by radial immunodiffusion was found significantly lower (19.2 +/- 6.8 mg%) than in controls (28.0 +/- +/- 5.2 mg%) (p less than 0.01). The level of antithrombin III is positively correlated with pseudo-cholinesterase and, less significantly with blood albumin. Therefore decreased antithrombin III reflects liver cell disfunction in cirrhosis and its decrease may predispose to thrombotic events which occur sporadically in cirrhosis.
抗凝血酶III是一种在肝细胞中合成的抗凝剂。本研究的目的是评估肝硬化患者血清中抗凝血酶III的水平。对32例肝硬化患者和20名健康对照者进行了调查。通过放射免疫扩散法测得的抗凝血酶III水平明显低于对照组(分别为19.2±6.8mg%和28.0±5.2mg%)(p<0.01)。抗凝血酶III水平与假胆碱酯酶呈正相关,与血白蛋白的相关性较弱。因此,抗凝血酶III水平降低反映了肝硬化患者的肝细胞功能障碍,其降低可能易导致肝硬化中偶尔发生的血栓形成事件。